An insightful article on COVID-19 testing was authored by Mara G. Aspinall co-founder of the biomedical diagnostics program at Arizona State University’s College of Health Solutions. Published October 9th. According to Aspinall, “PCR tests cost too much and take too long, too few will be tested and the results will arrive too late to act on them. Counterintuitively, less sensitive antigen tests are more effective at identifying those who could otherwise become super-spreaders.” Even if a less accurate antigen test misses the early hours of infectivity, it will definitely catch all cases by later that first day and on all subsequent…
Browsing: Diagnostics Tech
Mesa Biotech designs, develops, manufactures and commercializes next-generation molecular diagnostic tests, bringing the superior diagnostic performance of nucleic acid PCR amplification to the point-of-care. Mesa’s proprietary OSCAR technology is key to the patented and patent-pending diagnostic solutions. The technology offers the simplicity, convenience and procedural familiarity of traditional POC rapid immunoassays while providing the superior sensitivity and specificity of laboratory-based molecular testing. Mesa Biotech has developed a qualitative, visually read test utilizing polymerase chain reaction (PCR) technology to detect SARS-CoV-2, the virus responsible for COVID-19. Using throat and nasal swabs, results are available in 30 minutes, based on the principles…
Sherlock Biosciences, launched March of 2019, is an early-stage venture whose focus is to “develop affordable, instrument-free diagnostic tests for use in oncology and infectious diseases, as well as in industrial and agricultural applications. SHERLOCK is an evolution of CRISPR technology, which others use to make precise edits in genetic code. SHERLOCK can detect the unique genetic fingerprints of virtually any DNA or RNA sequence in any organism or pathogen. Developed by our founders and licensed exclusively from the Broad Institute, SHERLOCK is a method for single molecule detection of nucleic acid targets and stands for Specific High Sensitivity Enzymatic Reporter…
DecomBio, incorporated in California, consists of a multidisciplinary team of researchers and physicians at UCSF and UC Berkeley. They specialize in assembling, packaging and distributing colloidal gold diagnostic instruments in North America. Their product received acknowledgment from the U.S. FDA, with permission to distribute. [mepr-show rules=”18700″ unauth=”message”] DecomBio’s Noval Coronavirus (SARS- COV-2) IgM/IgG Combo Rapid Test uses Whole blood, serum, or plasma to direct the presence of the virus. The test can be used at home or administered by a healthcare professional and results are available in 20 minutes. The FDA has approved the test and is in the final stages of EUA…
Since 1990, Aurora has been serving the global scientific research community through the development of innovative laboratory solutions. The company started manufacturing analytical instrumentation based on a patented capacitively coupled plasma emission technology.The organization develops laboratory solutions, analytical instrumentation, and automated liquid handling platforms. [mepr-show rules=”18700″ unauth=”message”] Aurora Biomed developed its anitbody COVID-19 IgM/IgG Rapid Test Kit which can measure results in 10-15 minutes. The test uses Human serum, plasma, or whole blood and can be administered at home or under the supervision of medical personel. It is currently in development and price is available upon request. Aurora is a privately owned company and in 2000, Aurora became the first to develop…
BioSURE is a UK company specializing in the provision of rapid in-vitro diagnostic testing solutions. The BioSURE COVID-19 Self-Test will be an at-home antibody test that will use technology similar to that of a pregnancy test. The lateral flow chromatography assay test will detect the presence of IgG antibodies to the COVID-19 virus, not COVID-19 itself. The BioSURE COVID-19 Self-Test will be as easy as 3 simple steps. Prick, Suck and Poke. The finger-prick blood sample will provide results in 11 minutes. [mepr-show rules=”18700″ unauth=”message”] The BioSURE COVID-19 Self-Test was developed in partnership with Mologic, a leading developer of lateral flow and rapid diagnostic technologies,…
Market Overview was prepared by a team from Cambridge University. The objective was understanding of the testing market in Europe. The report also offers insight into Asia. The 50 page deck examined the COVID testing market broadly and assessed a variety of market dynamics: Market size for PCR and Antibody tests The different business models employed Regulatory pathways Supply chain analysis including bottlenecks. Regulatory landscape. Including a detailed flow chart analyzing zing the complexity of approval process in the EU, China and South Korea. Also included was the commercialization landscape and the reimbursement analysis for France, Germany, UK, Spain and…
[mepr-show rules=”18700″ unauth=”message”] Overview: SD Biosensor is a global bio-diagnostic company that provides in vitro diagnostic products engrafted with innovative technologies and know-hows. Founded in 2005, the company’s line of business includes the manufacturing of medical, surgical, ophthalmic, and veterinary instruments and apparatus. Test Name: STANDARD Q COVID-19 Ag Testing Type: Rapid antigen test Technology: STANDARD Q COVID-19 IgM/IgG Duo Test Kit is a rapid immunochromatography test designed for the qualitative presumptive detection of specific IgM and IgG to SARS-CoV-2 in humoral fluid. Test Sample Type: Nasopharyngeal swab Time to Result: 30 minutes Testing Location: Anywhere Complementary Products: Specimen: Nasopharyngeal swab Effectiveness: Sensitivity: 84%, Specificity: 100% Based on 32…